Satralizumab | Clinical Trial Radar | Chugai Pharmaceutical

Trial Radar AI Trial Candidate or Patient Patient Caregiver Healthcare Pro Biotech Pro Biotech Investor Researcher Other
	Let's discuss and explore clinical trials with Chugai Pharmaceutical as a lead sponsor or collaborator. I can help you find nearby clinical trials and understand health conditions and treatments.

Let's discuss and explore clinical trials with Chugai Pharmaceutical as a lead sponsor or collaborator.

I can help you find nearby clinical trials and understand health conditions and treatments.

Study Title	Status
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis (Cielo) NCT05503264	Recruiting
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (Meteoroid) NCT05271409	Recruiting
A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis NCT04963270	TerminatedResults Posted